What is Medichain?
MediChain is a Medical Big-Data Platform. It allows patients to store their own data offchain in an appropriate geographic domain, and give access to doctors and specialists anywhere regardless of the payer network or EMR used. MediChain is unque in medical records in as much as it does not just provide a patient solution but leverages the value of the data as big data.
Take Your Data Anywhere You Go
Move it between healthcare providers, specialists, insurers or even countries
Keep Data Safe and Anonymised
Patients decide how anonymised they want their medical data to be
No Cost for Patients or Doctors
Monetised by patients opting to let medical scientists and companies use data for research.
worth of problems solved
faster transaction speed
First, US big pharm spends $157 billion a year on research.
Second, Medical Errors are now the 3rd largest cause of death in the US costing $1 trillion in the US alone.
The Data Solution
Population-based de-identified patient data has already produced advances against WHO’s (World Health Organisation) top ten diseases including diabetes and heart failure.
Population data lets researchers tackle the big issues in medicine.
What MediChain Offers
Using Blockchain Technology, MediChain will promote these research breakthroughs.
Sharing Medical Data
By patients opting in and sharing their medical data, they will be able to help people who are suffering from similar health issues.
Additionally, sharing medical data will streamline the process of finding cures to the world’s worst diseases.
- Compact and highly skilled team with a lot of experience in startups, fintech and payment systems.
- Funds allocation seems great and well thought out in general
- Roadmap seems well thought out for the team and it’s size. Team is also planning to expand the team size by 60%.
- The logos shown on the website eg. Visa and Mastercard could be interpreted as partners, but can’t be verified. Possibility of exaggeration
- Information is not presented clearly either on the website or white paper. Most of the contributor-relevant information is scattered
- Low hard cap considering the expenditures associated with required licenses and institutional statuses